Sensorium Therapeutics Receives FDA IND Clearance for SNTX-2643, a First-in-Class, Rapid-Acting Anxiolytic
Nature-evolved chemistry, human insight, and AI converge to advance a new generation of brain and mental health medicines Company Appoints Jacob Hooker, PhD as CEO and Simba Gill, PhD, as Executive Chair Sensorium Therapeutics, Inc. (Sensorium), a neuroscience therapeutics company inspired by nature and guided by human biology to transform mental health treatment, announced today […]